Newspoint on MSN
EPF withdrawal after job exit: Should you cash out or stay invested? Key tax, interest & compounding rules explained
When people leave a job—whether for a career break, relocation, freelancing, or a new opportunity—one of the biggest financial questions they face is what to do with their Employees’ Provident Fund ...
Long-term wealth creation depends more on discipline, risk management and time in the market than on chasing multibaggers, Ashish Gupta, Chief Investment Officer of Axis AMC, said at the Mutual Fund ...
This article compares saving/investing and sports betting, and explains why the former tends to outperform the latter in monetary returns for most people.
According to Chuck Oliver, CEO of The Hidden Wealth Solution, tax planning should not be treated as an afterthought to investment management. Instead, it should serve as the structural foundation of a ...
Now, Novogain introduces an innovation that challenges this long-standing logic. Novogain has developed an AI-powered system ...
Good morning. Welcome, everyone, to the Vulcan Materials Company Fourth Quarter 2025 Earnings Call. My name is Angela, and I will be your conference call coordinator today. Please be reminded that ...
Poor stock performance is a prerequisite for many activist campaigns, but in the case of Norwegian Cruise Line and ...
Consumer Analyst Group of New York Conference 2026 February 16, 2026 7:00 PM ESTCompany ParticipantsDirk Van de Put ...
NEW YORK, NY, UNITED STATES, January 26, 2026 /EINPresswire.com/ -- When cyberattacks capture public attention, ...
Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite advances in modern medicine. In particular, mixed bacterial-viral infections in ...
The Kunming-Montreal Global Biodiversity Framework states that plastic pollution must be eliminated by 2030. So why haven't we enacted measures that make a real difference?
Biotech dealmaking is increasingly defined by a clear strategic shift: Pharmaceutical companies are prioritizing de-risked, late-stage assets with human clinical validation rather than speculative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results